CD8-Positive T-Lymphocytes
"CD8-Positive T-Lymphocytes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and CD8+ suppressor T-lymphocytes.
| Descriptor ID |
D018414
|
| MeSH Number(s) |
A11.118.637.555.567.569.220 A15.145.229.637.555.567.569.220 A15.382.490.555.567.569.220
|
| Concept/Terms |
CD8-Positive T-Lymphocytes- CD8-Positive T-Lymphocytes
- CD8 Positive T Lymphocytes
- CD8-Positive T-Lymphocyte
- T-Lymphocyte, CD8-Positive
- T-Lymphocytes, CD8-Positive
- T8 Lymphocytes
- Lymphocyte, T8
- Lymphocytes, T8
- T8 Lymphocyte
- T8 Cells
- Cell, T8
- Cells, T8
- T8 Cell
- CD8-Positive Lymphocytes
- CD8 Positive Lymphocytes
- CD8-Positive Lymphocyte
- Lymphocyte, CD8-Positive
- Lymphocytes, CD8-Positive
Suppressor T-Lymphocytes, CD8-Positive- Suppressor T-Lymphocytes, CD8-Positive
- CD8-Positive Suppressor T-Lymphocyte
- CD8-Positive Suppressor T-Lymphocytes
- Suppressor T Lymphocytes, CD8 Positive
- Suppressor T-Lymphocyte, CD8-Positive
- T-Lymphocyte, CD8-Positive Suppressor
- T-Lymphocytes, CD8-Positive Suppressor
- Suppressor T-Cells, CD8-Positive
- CD8-Positive Suppressor T-Cell
- CD8-Positive Suppressor T-Cells
- Suppressor T Cells, CD8 Positive
- Suppressor T-Cell, CD8-Positive
- T-Cell, CD8-Positive Suppressor
- T-Cells, CD8-Positive Suppressor
|
Below are MeSH descriptors whose meaning is more general than "CD8-Positive T-Lymphocytes".
Below are MeSH descriptors whose meaning is more specific than "CD8-Positive T-Lymphocytes".
This graph shows the total number of publications written about "CD8-Positive T-Lymphocytes" by people in this website by year, and whether "CD8-Positive T-Lymphocytes" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 3 | 5 | | 1997 | 3 | 0 | 3 | | 1998 | 3 | 2 | 5 | | 1999 | 3 | 3 | 6 | | 2000 | 4 | 1 | 5 | | 2001 | 5 | 4 | 9 | | 2002 | 9 | 4 | 13 | | 2003 | 4 | 2 | 6 | | 2004 | 5 | 7 | 12 | | 2005 | 9 | 6 | 15 | | 2006 | 8 | 11 | 19 | | 2007 | 11 | 9 | 20 | | 2008 | 11 | 11 | 22 | | 2009 | 9 | 6 | 15 | | 2010 | 11 | 2 | 13 | | 2011 | 7 | 6 | 13 | | 2012 | 10 | 5 | 15 | | 2013 | 15 | 7 | 22 | | 2014 | 15 | 8 | 23 | | 2015 | 13 | 6 | 19 | | 2016 | 18 | 12 | 30 | | 2017 | 16 | 6 | 22 | | 2018 | 14 | 16 | 30 | | 2019 | 15 | 14 | 29 | | 2020 | 14 | 13 | 27 | | 2021 | 19 | 18 | 37 | | 2022 | 6 | 13 | 19 | | 2023 | 9 | 18 | 27 | | 2024 | 22 | 14 | 36 | | 2025 | 20 | 12 | 32 | | 2026 | 11 | 8 | 19 |
To return to the timeline, click here.
Below are the most recent publications written about "CD8-Positive T-Lymphocytes" by people in Profiles.
-
Mickens KL, Jonsson AH. Reconciling CD8 T cell subsets: GZMK+, cytotoxic, resident memory, exhausted, and other CD8 T cells in blood and tissue. Front Immunol. 2026; 17:1905956.
-
Weaver AN, Keysar SB, Dureja A, Chimed TS, Le PN, Nieto C, Alzofon N, Morton JJ, Thomas CM, Lanning RM, Samedi VG, Van Bokhoven A, Jimeno A. Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes. Cancer Res Commun. 2026 Oct 01; 6(10):2350-2359.
-
Li X, Aguilar-Navarro AG, Nader M, Jahangiri S, Lee HS, Edun G, Gower M, Yang D, Fernandez M, Lin B, Oh D, Farhat S, Phillips DM, Bartman S, Murray D, Kaszuba C, Kossinna P, Kamath M, Whyne C, Schwartz G, Bajaj J, Kislinger T, Zhou BO, Coutu D, Akens M, Changoor A, Mallevaey T, Gaiti F, Jones C, Naik S, Minden M, Arruda A, Hitzler J, Lee KJ, Kim YM, Adams RH, Sivara KK, Tikhonova AN. IFN-? drives long-term bone marrow niche dysfunction following doxorubicin-based chemotherapy. Blood. 2026 09 03; 148(10):1277-1291.
-
Lingo JJ, Reis R, Koyas A, Voigt E, Zacharias ZR, Allamargot C, Hornick EL, Raygoza Garay JA, Kaemmer CA, Elias EC, Jabbari A, Wilhelm CR, Boyden AW, Karandikar NJ, Breheny P, Meyerholz DK, Dodd RD, Houtman JCD, Darbro BW, Quelle DE. Intratumoural plasma cells mediate a pro-inflammatory response to kinase inhibition and successful immune checkpoint blockade therapy in malignant peripheral nerve sheath tumours. EBioMedicine. 2026 Sep; 131:106413.
-
King HAD, Subra C, Tourtellott E, Swafford I, Basu S, Rossman M, Phillips L, Obarorakpor N, Ding S, Ferrari MG, Beck Z, Lewitus E, Bai H, Dong M, Slike BM, Kim D, Dussupt V, Mendez-Rivera L, Eisel N, Zhang L, Williams LD, Tomaras GD, Finzi A, Matyas GR, Krebs SJ, Rolland M, Rao M, Paquin-Proulx D, Bolton DL. Rapid and robust immune response boosting with potent, next-generation adjuvant in viral vector-primed primates. J Virol. 2026 Aug 18; 100(8):e0038926.
-
A Turner J, D'Antonio M, Montane HN, MacBeth M, Katsnelson E, Robinson WA, Tobin RP, Couts KL, Markovic SN, Torres RM. Targeting liver metastases in uveal melanoma: ATX-LPA mediated immunosuppression and novel therapeutic approaches. Front Immunol. 2026; 17:1829486.
-
Majumder A, Westrich JA, McNulty E, Sherman T, Carpenter M, Mayo C, Mathiason C, Perkins A. Mechanistic insights into Bluetongue virus immunodynamics: a Bayesian within-host modelling approach. J R Soc Interface. 2026 06 17; 23(239).
-
Freeman ML, Fitzgerald W, Clagett BM, O'Hare KA, Jonnalagadda V, Wilson BM, Margolis L, Wu K, Tassiopoulos K, Shive CL, Erlandson KM. Frailty in People with HIV Is Linked to Inflammation, Bone Health, and T-Cell Exhaustion. J Infect Dis. 2026 Jun 16; 233(6):995-1004.
-
Berger JN, Rosales A, Heiden D, Merrick C, Monogue B, Beckham JD, Berg L. Myeloid cell IL-15 production in the brain supports bystander CD8+ T cell neuropathic immune responses following virus infection. J Immunol. 2026 May 14; 215(5).
-
Bermack C, Singh S, Pei G, Patel SP, Wang L, Yee C. First-in-human use of recombinant IL-7 to potentiate antigen-specific T cell therapy: a single patient case study. J Immunother Cancer. 2026 Apr 30; 14(4).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|